Signatope
SIGNATOPE develops the next generation of protein biomarker assays using a special type of immunoaffinity based mass spectrometry assays.
Signatope is active in the rd tools space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.
The company sits in the rd tools segment, where it competes on its core product or service.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Directory data places it at the Seed stage.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $6K in funding.
| Sector | Rd Tools |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Country | Germany |
| Founded | 2017 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $600,000 |
Website: signatope.com
Browse related
Sign in to view the contact information we hold for Signatope.
Create a free account
Create a free account